What is Vera Therapeutics's stock issuance proceeds?

Vera Therapeutics (VERA) reported stock issuance proceeds of $3.94M in Q1 2026.

How has Vera Therapeutics's stock issuance proceeds changed year-over-year?

Vera Therapeutics's stock issuance proceeds increased by 157.1% year-over-year, from $1.53M to $3.94M.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Vera Therapeutics VERA Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Travere Therapeutics, Inc.TVTX

$4.73M+11.5%

Aurinia PharmaceuticalsAUPH

$713K-92.3%

Nektar TherapeuticsNKTR

$1.07B+506,582%

Viridian Therapeutics, Inc.VRDN

$0-100%

ImmunomeIMNM

$229K+7.5%

Iovance Biotherapeutics, Inc.IOVA

$98.51M-33.9%

Other financials

Income statement

See full

Operating income-$125.1M-119%

Net income-$121.0M-134%

EPS (diluted)-$1.69-109%

Balance sheet

See full

Cash & equivalents$114.4M+108%

Total debt$75.0M+37.8%

Total equity$499.7M-6.6%

Total assets$621.7M+1.9%

Cash flow

See full

Operating cash flow-$106.5M-95.8%

CapEx$23.0K-87.7%

Free cash flow-$106.5M-95.1%

Valuation

See full

Market cap$2.74B+87.5%

Enterprise value$2.7B+85.0%

Returns & leverage

See full

Return on equity-71.3%+296pp

Debt / equity0.2×0.0×

Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vera Therapeutics's stock issuance proceeds?: Vera Therapeutics (VERA) reported stock issuance proceeds of $3.94M in Q1 2026.
How has Vera Therapeutics's stock issuance proceeds changed year-over-year?: Vera Therapeutics's stock issuance proceeds increased by 157.1% year-over-year, from $1.53M to $3.94M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.